Financials
- Market Capitalization 1.96 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry 生物工学
総売上高
当期純利益
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-4.07
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2001 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.78 USD | -2.31% | -1.33% | +17.59% | +112.17% | 1.98 B USD | ||
| 2003 | ATAI AtaiBeckley Inc. - Common Stock | 5.36 USD | -5.47% | +2.88% | +30.10% | +35.70% | 1.97 B USD | ||
| 2011 | URGN UroGen Pharma Ltd. - Ordinary Shares | 39.80 USD | +1.56% | +4.24% | +22.46% | +109.47% | 1.94 B USD | ||
| 2013 | NBTX Nanobiotix S.A. - ADSs | 39.96 USD | -4.03% | +2.62% | +16.74% | +666.99% | 1.93 B USD |